IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lagoumintzis, G.
Right arrow Articles by Paliogianni, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lagoumintzis, G.
Right arrow Articles by Paliogianni, F.

 Previous Article  |  Next Article 

Infection and Immunity, August 2003, p. 4614-4622, Vol. 71, No. 8
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.8.4614-4622.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Pseudomonas aeruginosa Slime Glycolipoprotein Is a Potent Stimulant of Tumor Necrosis Factor Alpha Gene Expression and Activation of Transcription Activators Nuclear Factor {kappa}B and Activator Protein 1 in Human Monocytes

George Lagoumintzis, Myrto Christofidou, George Dimitracopoulos, and Fotini Paliogianni*

University of Patras Medical School, Department of Microbiology, Patras 26500, Greece

Received 13 January 2003/ Accepted 23 May 2003

Pseudomonas aeruginosa, an opportunistic pathogen, causes infections associated with a high incidence of morbidity and mortality in immunocompromised hosts. Production of tumor necrosis factor alpha (TNF-{alpha}), primarily by cells of monocytic lineage, is a crucial event in the course of these infections. During in vivo infections with P. aeruginosa, both lipopolysaccharide (LPS) and extracellular slime glycolipoprotein (GLP) produced by mucoid and nonmucoid strains are released. In the present study, we sought to explore the relative contributions of these two bacterial products to TNF-{alpha} production by human monocytes. To this end, fresh human monocytes and THP-1 human monocytic cells were stimulated with P. aeruginosa LPS or GLP. GLP was found to be a more potent stimulus for TNF-{alpha} production (threefold higher) by human monocytes than LPS. Moreover, its effect was comparable to that of viable bacteria. Quantitative mRNA analysis revealed predominantly transcriptional regulation. Electrophoretic mobility shift assays and transfection assays demonstrated activation of NF-{kappa}B and activator protein 1 (AP-1). NF-{kappa}B activation by GLP was rapid and followed the same time course as that by viable bacteria, suggesting that bacteria could directly activate NF-{kappa}B through GLP. Moreover P. aeruginosa GLP induced the formation of AP-1 complex with delayed kinetics compared with NF-{kappa}B but much more efficiently than the homologous LPS. These results identify GLP as the most important stimulant for TNF-{alpha} production by human monocytes. Activation of NF-{kappa}B and AP-1 by P. aeruginosa GLP may be involved not only in TNF-{alpha} induction but also in many of the inflammatory responses triggered in the course of infection with P. aeruginosa.


* Corresponding author. Mailing address: University of Patras Medical School, Department of Microbiology, Patras 26500, Greece. Phone: 30-610-999660. Fax: 30-610-994922. E-mail: FPAL{at}MED.UPATRAS.GR.

Editor: J. D. Clements


Infection and Immunity, August 2003, p. 4614-4622, Vol. 71, No. 8
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.8.4614-4622.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2003 by the American Society for Microbiology. All rights reserved.